Literature DB >> 31881248

Gambling and substance use: Comorbidity and treatment implications.

Jon E Grant1, Samuel R Chamberlain2.   

Abstract

Gambling disorder is a common condition that was previously listed as an impulse control disorder, but is now considered a substance-related and addictive disorder. Gambling disorder has been associated with various untoward long-term outcomes including impaired quality of life, relationship break-ups, debt and mortgage foreclosure, and elevated risk of suicidality. This paper provides a concise primer on gambling disorder, with a special focus on its parallels with substance use disorders. We consider clinical presentations, comorbid expression, heritability, and treatment approaches (psychological and pharmacological). Lastly, we highlight new treatment directions suggested by the literature.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Year:  2019        PMID: 31881248     DOI: 10.1016/j.pnpbp.2019.109852

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  4 in total

1.  Using the Risk-Return Model to Explain Gambling Disorder Symptoms in Youth: An Empirical Investigation with Italian Adolescents.

Authors:  Maria Anna Donati; Joshua Weller; Caterina Primi
Journal:  J Gambl Stud       Date:  2021-01-03

2.  Latent Classes for the Treatment Outcomes in Women with Gambling Disorder and Buying/Shopping Disorder.

Authors:  Roser Granero; Fernando Fernández-Aranda; Milagros Lizbeth Lara-Huallipe; Mónica Gómez-Peña; Laura Moragas; Isabel Baenas; Astrid Müller; Matthias Brand; Claudia Sisquellas; Susana Jiménez-Murcia
Journal:  J Clin Med       Date:  2022-07-05       Impact factor: 4.964

3.  Profiling of Gamblers and Problem Gamblers Among Casino Patrons in Macao SAR.

Authors:  Wai Ming To; Gui-Hai Huang
Journal:  J Gambl Stud       Date:  2022-08-12

4.  Family history of substance use disorders: Significance for mental health in young adults who gamble.

Authors:  Jon E Grant; Samuel R Chamberlain
Journal:  J Behav Addict       Date:  2020-06-05       Impact factor: 6.756

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.